Loading...
XHKG0030
Market cap155mUSD
Dec 23, Last price  
0.18HKD
1D
0.56%
1Q
122.50%
Jan 2017
36.92%
Name

Ban Loong Holdings Ltd

Chart & Performance

D1W1MN
XHKG:0030 chart
P/E
6.32
P/S
1.57
EPS
0.03
Div Yield, %
0.00%
Shrs. gr., 5y
8.53%
Rev. gr., 5y
-3.25%
Revenues
772m
+70.38%
25,041,85941,028,51473,784,184150,249,600108,878,606130,257,679103,409,027115,025,51468,747,91359,965,27556,403,923116,373,626299,259,373767,607,149910,081,9101,162,153,6351,216,714,366179,527,751452,908,674771,655,095
Net income
192m
P
85,468,32313,130,1027,619,441-5,546,77968,552,356-5,266,108-23,143,67512,554,422-22,258,263-23,453,872-33,579,904-23,470,398-191,218,035-1,465,73544,271,81449,573,53313,207,234-1,117,313,589-168,870,808191,659,916
CFO
61m
P
-6,687,953-10,385,352-6,736,40617,617,2496,382,284-3,462,557-8,114,431-18,450,806-17,195,980-17,568,140-31,490,338-144,795,065-130,843,324-178,054,171-257,476,350-53,564,900-178,681,434-4,479,698-140,980,13161,120,157
Dividend
Aug 05, 20080.5866 HKD/sh

Profile

Ban Loong Holdings Limited, an investment holding company, engages in the money lending, and trading of goods and commodities in Hong Kong, the People's Republic of China, and internationally. The company operates through Money Lending; Trading of Goods and Commodities; and Cannabidiol (CBD) isolate segments. It provides short-term personal and corporate loans; and trades in refined edible oil, sugar, cosmetic, cannabidiol, and personal care products. Ban Loong Holdings Limited has a strategic cooperation agreement with Alpex Pharma SA to cooperate on the development and commercialization of nutraceutical products. The company was formerly known as ABC Communications (Holdings) Limited and changed its name to Ban Loong Holdings Limited in October 2015. Ban Loong Holdings Limited is based in Wan Chai, Hong Kong.
URL
http://0030.com.hk
IPO date
Oct 09, 1991
Employees
33
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
771,655
329.82%
452,909
152.28%
179,528
-85.24%
Cost of revenue
753,129
481,781
712,784
Unusual Expense (Income)
NOPBT
18,526
(28,872)
(533,256)
NOPBT Margin
2.40%
Operating Taxes
3,562
2,956
3,439
Tax Rate
19.23%
NOPAT
14,964
(31,828)
(536,695)
Net income
191,660
-117.15%
(168,871)
-84.89%
(1,117,314)
-8,559.86%
Dividends
Dividend yield
Proceeds from repurchase of equity
100,252
BB yield
Debt
Debt current
34,258
16,369
18,987
Long-term debt
35,344
14,195
12,008
Deferred revenue
Other long-term liabilities
(9,843)
(11,343)
Net debt
(129,738)
(442,152)
(221,198)
Cash flow
Cash from operating activities
61,120
(140,980)
(4,480)
CAPEX
(4,926)
(393)
(290)
Cash from investing activities
(4,661)
(289)
(248)
Cash from financing activities
(852)
98,839
(44,234)
FCF
(65,106)
(25,841)
570,343
Balance
Cash
199,324
472,699
252,193
Long term investments
16
17
Excess cash
160,757
450,071
243,216
Stockholders' equity
(839,596)
(1,038,567)
(785,102)
Invested Capital
1,128,721
1,179,680
1,010,657
ROIC
1.40%
ROCE
6.41%
EV
Common stock shares outstanding
8,737,899
6,736,308
6,448,152
Price
0.26
-43.96%
Market cap
1,644,279
-43.96%
EV
1,423,998
EBITDA
24,192
(23,300)
(523,534)
EV/EBITDA
Interest
5,906
3,851
Interest/NOPBT